| UniProt ID | ERGI1_HUMAN | |
|---|---|---|
| UniProt AC | Q969X5 | |
| Protein Name | Endoplasmic reticulum-Golgi intermediate compartment protein 1 | |
| Gene Name | ERGIC1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 290 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . Endoplasmic reticulum-Golgi intermediate compartment membrane Multi-pass membrane protein . Golgi apparatus membrane Multi-pass membrane protein . Cycles between the endoplasmic retic |
|
| Protein Description | Possible role in transport between endoplasmic reticulum and Golgi.. | |
| Protein Sequence | MPFDFRRFDIYRKVPKDLTQPTYTGAIISICCCLFILFLFLSELTGFITTEVVNELYVDDPDKDSGGKIDVSLNISLPNLHCELVGLDIQDEMGRHEVGHIDNSMKIPLNNGAGCRFEGQFSINKVPGNFHVSTHSATAQPQNPDMTHVIHKLSFGDTLQVQNIHGAFNALGGADRLTSNPLASHDYILKIVPTVYEDKSGKQRYSYQYTVANKEYVAYSHTGRIIPAIWFRYDLSPITVKYTERRQPLYRFITTICAIIGGTFTVAGILDSCIFTASEAWKKIQLGKMH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 11 | Phosphorylation | DFRRFDIYRKVPKDL CCCCCCCCCCCCCCC | 13.26 | - | |
| 14 | Ubiquitination | RFDIYRKVPKDLTQP CCCCCCCCCCCCCCC | 5.43 | 21963094 | |
| 74 | N-linked_Glycosylation | GKIDVSLNISLPNLH CEEEEEEEEECCCCE | 17.81 | 15308636 | |
| 98 | Ubiquitination | DEMGRHEVGHIDNSM CCCCCCCCCCCCCCC | 5.74 | 21890473 | |
| 98 (in isoform 2) | Ubiquitination | - | 5.74 | 21890473 | |
| 106 | Ubiquitination | GHIDNSMKIPLNNGA CCCCCCCEEECCCCC | 40.78 | 21963094 | |
| 122 | Ubiquitination | CRFEGQFSINKVPGN EEEEEEEEEEECCCC | 19.84 | 21963094 | |
| 130 | Ubiquitination | INKVPGNFHVSTHSA EEECCCCEEEEECCC | 8.14 | 21963094 | |
| 138 | O-linked_Glycosylation | HVSTHSATAQPQNPD EEEECCCCCCCCCCC | 28.92 | OGP | |
| 149 (in isoform 2) | Ubiquitination | - | 3.45 | 21890473 | |
| 149 | Ubiquitination | QNPDMTHVIHKLSFG CCCCCCEEEEECCCC | 3.45 | 21890473 | |
| 184 | Phosphorylation | LTSNPLASHDYILKI CCCCCCCCCCEEEEE | 25.28 | 28152594 | |
| 187 | Phosphorylation | NPLASHDYILKIVPT CCCCCCCEEEEEECE | 11.61 | 28152594 | |
| 190 (in isoform 1) | Ubiquitination | - | 31.90 | 21890473 | |
| 190 | Acetylation | ASHDYILKIVPTVYE CCCCEEEEEECEEEE | 31.90 | 27452117 | |
| 190 | 2-Hydroxyisobutyrylation | ASHDYILKIVPTVYE CCCCEEEEEECEEEE | 31.90 | - | |
| 190 | Ubiquitination | ASHDYILKIVPTVYE CCCCEEEEEECEEEE | 31.90 | 21906983 | |
| 196 | Ubiquitination | LKIVPTVYEDKSGKQ EEEECEEEECCCCCE | 22.38 | 27667366 | |
| 196 | Phosphorylation | LKIVPTVYEDKSGKQ EEEECEEEECCCCCE | 22.38 | - | |
| 199 | 2-Hydroxyisobutyrylation | VPTVYEDKSGKQRYS ECEEEECCCCCEEEE | 49.52 | - | |
| 199 | Ubiquitination | VPTVYEDKSGKQRYS ECEEEECCCCCEEEE | 49.52 | 33845483 | |
| 202 | Ubiquitination | VYEDKSGKQRYSYQY EEECCCCCEEEEEEE | 38.40 | - | |
| 209 | Phosphorylation | KQRYSYQYTVANKEY CEEEEEEEEECCCEE | 8.57 | 18491316 | |
| 214 | Ubiquitination | YQYTVANKEYVAYSH EEEEECCCEEEEEEC | 40.46 | 21890473 | |
| 216 | Phosphorylation | YTVANKEYVAYSHTG EEECCCEEEEEECCC | 7.62 | - | |
| 219 | Phosphorylation | ANKEYVAYSHTGRII CCCEEEEEECCCCEE | 7.31 | - | |
| 236 | Phosphorylation | IWFRYDLSPITVKYT EEEECCCCCCEEEEC | 16.03 | - | |
| 238 | Ubiquitination | FRYDLSPITVKYTER EECCCCCCEEEECCC | 6.59 | 21963094 | |
| 239 | Phosphorylation | RYDLSPITVKYTERR ECCCCCCEEEECCCC | 17.84 | 25599653 | |
| 241 | Ubiquitination | DLSPITVKYTERRQP CCCCCEEEECCCCCH | 37.49 | 21963094 | |
| 241 | 2-Hydroxyisobutyrylation | DLSPITVKYTERRQP CCCCCEEEECCCCCH | 37.49 | - | |
| 241 (in isoform 1) | Ubiquitination | - | 37.49 | 21890473 | |
| 241 | Acetylation | DLSPITVKYTERRQP CCCCCEEEECCCCCH | 37.49 | 27452117 | |
| 243 | Phosphorylation | SPITVKYTERRQPLY CCCEEEECCCCCHHH | 19.80 | 25599653 | |
| 265 | Ubiquitination | AIIGGTFTVAGILDS HHHCCCCCHHHHHHH | 14.86 | 21890473 | |
| 273 | S-palmitoylation | VAGILDSCIFTASEA HHHHHHHHCEECHHH | 2.71 | 29575903 | |
| 288 | Malonylation | WKKIQLGKMH----- HHHHHCCCCC----- | 42.25 | 26320211 | |
| 288 | Ubiquitination | WKKIQLGKMH----- HHHHHCCCCC----- | 42.25 | 33845483 | |
| 312 | Ubiquitination | ----------------------------- ----------------------------- | 27667366 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ERGI1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ERGI1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ERGI1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ERGI3_HUMAN | ERGIC3 | physical | 15308636 | |
| FAF2_HUMAN | FAF2 | physical | 22939629 | |
| GNAI2_HUMAN | GNAI2 | physical | 22939629 | |
| TOM7_HUMAN | TOMM7 | physical | 22939629 | |
| VATB1_HUMAN | ATP6V1B1 | physical | 22939629 | |
| HIG1A_HUMAN | HIGD1A | physical | 22939629 | |
| ITA2_HUMAN | ITGA2 | physical | 22939629 | |
| NDUV1_HUMAN | NDUFV1 | physical | 22939629 | |
| RM11_HUMAN | MRPL11 | physical | 22939629 | |
| RM32_HUMAN | MRPL32 | physical | 22939629 | |
| UCRI_HUMAN | UQCRFS1 | physical | 22939629 | |
| IST1_HUMAN | IST1 | physical | 22939629 | |
| ICT1_HUMAN | ICT1 | physical | 22939629 | |
| GOGB1_HUMAN | GOLGB1 | physical | 22939629 | |
| AINX_HUMAN | INA | physical | 26186194 | |
| EFNB1_HUMAN | EFNB1 | physical | 26186194 | |
| AINX_HUMAN | INA | physical | 28514442 | |
| EFNB1_HUMAN | EFNB1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-74, AND MASS SPECTROMETRY. | |
| "Proteomics of endoplasmic reticulum-Golgi intermediate compartment(ERGIC) membranes from brefeldin A-treated HepG2 cells identifiesERGIC-32, a new cycling protein that interacts with human Erv46."; Breuza L., Halbeisen R., Jenoe P., Otte S., Barlowe C., Hong W.,Hauri H.-P.; J. Biol. Chem. 279:47242-47253(2004). Cited for: PROTEIN SEQUENCE OF 177-199 AND 233-241, SUBCELLULAR LOCATION,TOPOLOGY, GLYCOSYLATION, AND INTERACTION WITH ERGIC3. | |